{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:25:55Z","timestamp":1781529955279,"version":"3.54.1"},"reference-count":136,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472677"],"award-info":[{"award-number":["81472677"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX10203207"],"award-info":[{"award-number":["2017ZX10203207"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.gendis.2020.01.016","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T05:49:13Z","timestamp":1581054553000},"page":"299-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The fuel and engine: The roles of reprogrammed metabolism in metastasis of primary liver cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Wen-Wei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4805-8239","authenticated-orcid":false,"given":"Lun-Xiu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gendis.2020.01.016_bib1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gendis.2020.01.016_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.gendis.2020.01.016_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib4","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1158\/0008-5472.CAN-16-0266","article-title":"Metabolic plasticity as a determinant of tumor growth and metastasis","volume":"76","author":"Lehu\u00e9d\u00e9","year":"2016","journal-title":"Canc Res"},{"key":"10.1016\/j.gendis.2020.01.016_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.gendis.2020.01.016_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metabol"},{"key":"10.1016\/j.gendis.2020.01.016_bib7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.gendis.2020.01.016_bib8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.molcel.2013.01.035","article-title":"AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1","volume":"49","author":"Wu","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib9","first-page":"1164","article-title":"Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers","volume":"56","author":"Younes","year":"1996","journal-title":"Canc Res"},{"key":"10.1016\/j.gendis.2020.01.016_bib10","first-page":"928","article-title":"Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix","volume":"7","author":"Airley","year":"2001","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.gendis.2020.01.016_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/bjc.2016.26","article-title":"Hexokinase 2 is a determinant of neuroblastoma metastasis","volume":"114","author":"Botzer","year":"2016","journal-title":"Br J Canc"},{"key":"10.1016\/j.gendis.2020.01.016_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.gendis.2020.01.016_bib13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jcp.20166","article-title":"Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer","volume":"202","author":"Macheda","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.gendis.2020.01.016_bib14","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2353\/ajpath.2009.080596","article-title":"GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis","volume":"174","author":"Amann","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gendis.2020.01.016_bib15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12032-011-9841-z","article-title":"Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II","volume":"29","author":"Gong","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.gendis.2020.01.016_bib16","doi-asserted-by":"crossref","first-page":"94ra70","DOI":"10.1126\/scitranslmed.3002394","article-title":"Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality","volume":"3","author":"Chan","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.gendis.2020.01.016_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","article-title":"Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer","volume":"24","author":"Patra","year":"2013","journal-title":"Canc Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib18","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.celrep.2014.07.053","article-title":"Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth","volume":"8","author":"Wang","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.gendis.2020.01.016_bib19","doi-asserted-by":"crossref","first-page":"11577","DOI":"10.1073\/pnas.1508871112","article-title":"p63 supports aerobic respiration through hexokinase II","volume":"112","author":"Viticchie","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gendis.2020.01.016_bib20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.27929","article-title":"MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer","volume":"62","author":"Guo","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.gendis.2020.01.016_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia--a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.gendis.2020.01.016_bib22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.gendis.2020.01.016_bib23","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1158\/1078-0432.CCR-10-1360","article-title":"Hypoxia and hypoxia-inducible factors: master regulators of metastasis","volume":"16","author":"Lu","year":"2010","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.gendis.2020.01.016_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12094-012-0924-x","article-title":"Novel insight into the role of GAPDH playing in tumor","volume":"15","author":"Guo","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.gendis.2020.01.016_bib25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/hep.510230413","article-title":"Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28s-ribosomal RNA gene expression in human hepatocellular carcinoma","volume":"23","author":"Gong","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.gendis.2020.01.016_bib26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2020.01.016_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12943-015-0462-6","article-title":"PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma","volume":"14","author":"Yu","year":"2015","journal-title":"Mol Canc"},{"key":"10.1016\/j.gendis.2020.01.016_bib28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2013.09.025","article-title":"PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells","volume":"155","author":"Israelsen","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nature06667","article-title":"Pyruvate kinase M2 is a phosphotyrosine-binding protein","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2020.01.016_bib30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nchembio.1060","article-title":"Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis","volume":"8","author":"Anastasiou","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.gendis.2020.01.016_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature10598","article-title":"Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation","volume":"480","author":"Yang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2020.01.016_bib32","doi-asserted-by":"crossref","first-page":"7882","DOI":"10.1038\/ncomms8882","article-title":"PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation","volume":"6","author":"Iansante","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.gendis.2020.01.016_bib33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molcel.2011.04.025","article-title":"Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth","volume":"42","author":"Lv","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib34","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1211485","article-title":"Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses","volume":"334","author":"Anastasiou","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.gendis.2020.01.016_bib35","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","article-title":"Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1","volume":"145","author":"Luo","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib36","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.molcel.2012.01.001","article-title":"Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase","volume":"45","author":"Gao","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cmet.2015.08.007","article-title":"PDK1-Dependent metabolic reprogramming dictates metastatic potential in breast cancer","volume":"22","author":"Dupuy","year":"2015","journal-title":"Cell Metabol"},{"key":"10.1016\/j.gendis.2020.01.016_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0014-5793(71)80200-4","article-title":"The transport of pyruvate in rat liver mitochondria","volume":"12","author":"Papa","year":"1971","journal-title":"FEBS Lett"},{"key":"10.1016\/j.gendis.2020.01.016_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.1218099","article-title":"A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans","volume":"337","author":"Bricker","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.gendis.2020.01.016_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1218530","article-title":"Identification and functional expression of the mitochondrial pyruvate carrier","volume":"337","author":"Herzig","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.gendis.2020.01.016_bib41","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","article-title":"A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth","volume":"56","author":"Schell","year":"2014","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.gendis.2020.01.016_bib42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ccell.2018.12.012","article-title":"Wild-type p53 promotes cancer metabolic switch by inducing PUMA-dependent suppression of oxidative phosphorylation","volume":"35","author":"Kim","year":"2019","journal-title":"Canc Cell"},{"issue":"10","key":"10.1016\/j.gendis.2020.01.016_bib43","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.celrep.2019.07.098","article-title":"Disrupting mitochondrial pyruvate uptake directs glutamine into the TCA cycle away from glutathione synthesis and impairs hepatocellular tumorigenesis","volume":"28","author":"Tompkins","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.gendis.2020.01.016_bib44","doi-asserted-by":"crossref","first-page":"42180","DOI":"10.1074\/jbc.M112.417832","article-title":"Isocitrate dehydrogenase (IDH) mutations promote a reversible ZEB1\/microRNA(miR)-200-dependent epithelial-mesenchymal transition (EMT)","volume":"287","author":"Grassian","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gendis.2020.01.016_bib45","doi-asserted-by":"crossref","first-page":"E954","DOI":"10.1210\/jc.2011-3437","article-title":"Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations","volume":"97","author":"Loriot","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gendis.2020.01.016_bib46","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature19353","article-title":"Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition","volume":"537","author":"Sciacovelli","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2020.01.016_bib47","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41419-018-0961-7","article-title":"O-GlcNAcylation on Rab3A attenuates its effects on mitochondrial oxidative phosphorylation and metastasis in hepatocellular carcinoma","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.gendis.2020.01.016_bib48","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00432-014-1888-8","article-title":"Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration","volume":"141","author":"Gao","year":"2015","journal-title":"J Canc Res Clin Oncol"},{"key":"10.1016\/j.gendis.2020.01.016_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13046-018-0673-y","article-title":"Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt\/\u03b2-catenin signaling pathway activation in hepatocellular carcinoma cells","volume":"37","author":"Fan","year":"2018","journal-title":"J Exp Clin Canc Res"},{"key":"10.1016\/j.gendis.2020.01.016_bib50","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gendis.2020.01.016_bib51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2006.04.023","article-title":"Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance","volume":"9","author":"Fantin","year":"2006","journal-title":"Canc Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib52","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1111\/j.1742-4658.2012.08748.x","article-title":"Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma","volume":"279","author":"Sheng","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/j.gendis.2020.01.016_bib53","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1499-3872(15)60353-8","article-title":"Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma","volume":"14","author":"Wang","year":"2015","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.gendis.2020.01.016_bib54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2407-14-110","article-title":"The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management","volume":"14","author":"Faloppi","year":"2014","journal-title":"BMC Canc"},{"key":"10.1016\/j.gendis.2020.01.016_bib55","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10585-005-2343-7","article-title":"Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer","volume":"22","author":"Koukourakis","year":"2005","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.gendis.2020.01.016_bib56","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature16967","article-title":"Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities","volume":"531","author":"Kerr","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2020.01.016_bib57","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ccr.2013.02.005","article-title":"Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer","volume":"23","author":"Zhao","year":"2013","journal-title":"Canc Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib58","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1158\/1078-0432.CCR-11-0397","article-title":"Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype","volume":"17","author":"Serganova","year":"2011","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.gendis.2020.01.016_bib59","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"PGC-1\u03b1 mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis","volume":"16","author":"Lebleu","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.gendis.2020.01.016_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metabol"},{"key":"10.1016\/j.gendis.2020.01.016_bib61","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2015.447","article-title":"Glutaminolysis as a target for cancer therapy","volume":"35","author":"Jin","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.gendis.2020.01.016_bib62","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.18632\/oncotarget.6879","article-title":"Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.gendis.2020.01.016_bib63","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.canlet.2016.10.012","article-title":"Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells","volume":"383","author":"Kuo","year":"2016","journal-title":"Canc Lett"},{"key":"10.1016\/j.gendis.2020.01.016_bib64","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","article-title":"The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type","volume":"15","author":"Yuneva","year":"2012","journal-title":"Cell Metabol"},{"key":"10.1016\/j.gendis.2020.01.016_bib65","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1038\/onc.2015.381","article-title":"ASCT2\/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer","volume":"35","author":"van Geldermalsen","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.gendis.2020.01.016_bib66","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1111\/j.1742-4658.2012.08644.x","article-title":"Lipid metabolism in cancer","volume":"279","author":"Santos","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/j.gendis.2020.01.016_bib67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metabol"},{"key":"10.1016\/j.gendis.2020.01.016_bib68","first-page":"254","article-title":"Emerging roles of lipid metabolism in cancer progression","volume":"20","author":"Corbet","year":"2017","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.gendis.2020.01.016_bib69","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1053\/j.gastro.2013.01.054","article-title":"Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes","volume":"144","author":"Budhu","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gendis.2020.01.016_bib70","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jhep.2008.07.036","article-title":"Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma","volume":"50","author":"Yamashita","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.gendis.2020.01.016_bib71","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/1389450115666141224125117","article-title":"ATP Citrate Lyase (ACLY): a promising target for cancer prevention and treatment","volume":"16","author":"Khwairakpam","year":"2015","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.gendis.2020.01.016_bib72","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.gendis.2020.01.016_bib73","first-page":"515","article-title":"Acetyl-CoA carboxylase-a as a novel target for cancer therapy","volume":"2","author":"Wang","year":"2010","journal-title":"Front Biosci"},{"key":"10.1016\/j.gendis.2020.01.016_bib74","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ajpath.2011.04.030","article-title":"Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice","volume":"179","author":"Huang","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gendis.2020.01.016_bib75","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MOL.0b013e32834b0d7f","article-title":"Genetics and molecular biology: fatty acid metabolism in cancer cell survival; carnitine palmitoyltransferase-1 as a critical anticancer target","volume":"22","author":"Rotondo","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.gendis.2020.01.016_bib76","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2015.07.039","article-title":"CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt\/mTOR\/SREBP1c and P38\/PPAR\u03b1 pathways","volume":"63","author":"Li","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.gendis.2020.01.016_bib77","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.290.5497.1721","article-title":"How cells handle cholesterol","volume":"290","author":"Simons","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.gendis.2020.01.016_bib78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.gendis.2020.01.016_bib79","doi-asserted-by":"crossref","first-page":"15051","DOI":"10.1073\/pnas.0910258107","article-title":"Dysregulation of the mevalonate pathway promotes transformation","volume":"107","author":"Clendening","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gendis.2020.01.016_bib80","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gad.189365.112","article-title":"Links between metabolism and cancer","volume":"26","author":"Dang","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.gendis.2020.01.016_bib81","first-page":"31","article-title":"Biological role of liver X receptors","volume":"59","author":"Baranowski","year":"2008","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.gendis.2020.01.016_bib82","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12253-017-0249-8","article-title":"Tumor LXR expression is a prognostic marker for patients with hepatocellular carcinoma","volume":"24","author":"Long","year":"2018","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.gendis.2020.01.016_bib83","doi-asserted-by":"crossref","first-page":"E3127","DOI":"10.3390\/ijms19103127","article-title":"Emodin sensitizes hepatocellular carcinoma cells to the anti-cancer effect of sorafenib through suppression of cholesterol metabolism","volume":"19","author":"Kim","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2020.01.016_bib84","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jmcb\/mjt039","article-title":"A specific cholesterol metabolic pathway is established in a subset of HCCs for tumor growth","volume":"5","author":"Lu","year":"2013","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.gendis.2020.01.016_bib85","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neuropharm.2008.02.019","article-title":"Lipid rafts, cholesterol, and the brain","volume":"55","author":"Korade","year":"2008","journal-title":"Neuropharmacology"},{"issue":"Suppl","key":"10.1016\/j.gendis.2020.01.016_bib86","doi-asserted-by":"crossref","first-page":"S323","DOI":"10.1194\/jlr.R800040-JLR200","article-title":"The challenge of lipid rafts","volume":"50","author":"Pike","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.gendis.2020.01.016_bib87","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0854.2004.0181.x","article-title":"Lipids as targeting signals: lipid rafts and intracellular trafficking","volume":"5","author":"Helms","year":"2004","journal-title":"Traffic"},{"key":"10.1016\/j.gendis.2020.01.016_bib88","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2018.04.038","article-title":"Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts","volume":"429","author":"Yang","year":"2018","journal-title":"Canc Lett"},{"key":"10.1016\/j.gendis.2020.01.016_bib89","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cmet.2015.05.014","article-title":"Acetyl coenzyme A: a central metabolite and second messenger","volume":"21","author":"Pietrocola","year":"2015","journal-title":"Cell Metabol"},{"key":"10.1016\/j.gendis.2020.01.016_bib90","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ceb.2015.02.003","article-title":"Acetyl-CoA and the regulation of metabolism: mechanisms and consequences","volume":"33","author":"Shi","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.gendis.2020.01.016_bib91","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.plipres.2010.04.001","article-title":"Functional and structural properties of mammalian acyl-coenzyme A thioesterases","volume":"49","author":"Kirkby","year":"2010","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.gendis.2020.01.016_bib92","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2014.11.020","article-title":"Acetate dependence of tumors","volume":"159","author":"Comerford","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib93","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cmet.2018.12.019","article-title":"ACOT12-Dependent alteration of Acetyl-CoA drives hepatocellular carcinoma metastasis by epigenetic induction of epithelial-mesenchymal transition","volume":"29","author":"Lu","year":"2019","journal-title":"Cell Metabol"},{"key":"10.1016\/j.gendis.2020.01.016_bib94","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cmet.2017.09.018","article-title":"Acetyl-CoA carboxylase 1-dependent protein acetylation controls breast cancer metastasis and recurrence","volume":"26","author":"Rios Garcia","year":"2017","journal-title":"Cell Metabol"},{"key":"10.1016\/j.gendis.2020.01.016_bib95","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1101\/gad.311027.117","article-title":"Acetyl-CoA promotes glioblastoma cell adhesion and migration through Ca2+-NFAT signaling","volume":"32","author":"Lee","year":"2018","journal-title":"Genes Dev"},{"issue":"10","key":"10.1016\/j.gendis.2020.01.016_bib96","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1158\/0008-5472.CAN-17-2392","article-title":"Organelle-derived acetyl-CoA promotes prostate cancer cell survival, migration, and metastasis via activation of calmodulin kinase II","volume":"78","author":"Yu","year":"2018","journal-title":"Canc Res"},{"key":"10.1016\/j.gendis.2020.01.016_bib97","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tig.2008.10.012","article-title":"Co-evolution of tumor cells and their microenvironment","volume":"25","author":"Polyak","year":"2009","journal-title":"Trends Genet"},{"key":"10.1016\/j.gendis.2020.01.016_bib98","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib99","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.gde.2010.11.001","article-title":"Environment, inflammation, and cancer","volume":"21","author":"Sansone","year":"2011","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.gendis.2020.01.016_bib100","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumor microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.gendis.2020.01.016_bib101","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jhep.2010.10.013","article-title":"Potential of immunotherapy for hepatocellular carcinoma","volume":"54","author":"Breous","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.gendis.2020.01.016_bib102","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","article-title":"Breakthrough of the year 2013. Cancer immunotherapy","volume":"342","author":"Couzin-Frankel","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.gendis.2020.01.016_bib103","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12307-012-0111-1","article-title":"Inflammatory immune responses in tumor microenvironment and metastasis of hepatocellular carcinoma","volume":"5","author":"Qin","year":"2012","journal-title":"Cancer Microenviron"},{"key":"10.1016\/j.gendis.2020.01.016_bib104","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib105","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.canlet.2014.10.021","article-title":"Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin","volume":"356","author":"Song","year":"2015","journal-title":"Canc Lett"},{"key":"10.1016\/j.gendis.2020.01.016_bib106","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.gendis.2020.01.016_bib107","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","article-title":"Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay","volume":"72","author":"Fiaschi","year":"2012","journal-title":"Canc Res"},{"key":"10.1016\/j.gendis.2020.01.016_bib108","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.4161\/cc.9.17.12731","article-title":"Ketones and lactate \"fuel\" tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism","volume":"9","author":"Bonuccelli","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.gendis.2020.01.016_bib109","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev-pathol-011811-120856","article-title":"Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms","volume":"7","author":"Sotgia","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.gendis.2020.01.016_bib110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2014.05.004","article-title":"Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis","volume":"26","author":"Valencia","year":"2014","journal-title":"Canc Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib111","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.celrep.2015.02.006","article-title":"Metabolic reprogramming of cancer-associated fibroblasts by IDH3\u03b1 downregulation","volume":"10","author":"Zhang","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.gendis.2020.01.016_bib112","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.4161\/cc.21384","article-title":"Metabolic reprogramming of cancer-associated fibroblasts by TGF-\u03b2 drives tumor growth: connecting TGF-\u03b2 signaling with \"Warburg-like\" cancer metabolism and L-lactate production","volume":"11","author":"Guido","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.gendis.2020.01.016_bib113","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/gutjnl-2019-318419","article-title":"Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade","volume":"68","author":"Zhu","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.gendis.2020.01.016_bib114","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/eji.201445427","article-title":"Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal","volume":"46","author":"Mills","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.gendis.2020.01.016_bib115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2014.05.008","article-title":"Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"352","author":"Fan","year":"2014","journal-title":"Canc Lett"},{"key":"10.1016\/j.gendis.2020.01.016_bib116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metabol"},{"key":"10.1016\/j.gendis.2020.01.016_bib117","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1096\/fj.14-268409","article-title":"Essential role of mitochondrial energy metabolism in Foxp3+ T-regulatory cell function and allograft survival","volume":"29","author":"Beier","year":"2015","journal-title":"Faseb J"},{"key":"10.1016\/j.gendis.2020.01.016_bib118","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.20110278","article-title":"HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.gendis.2020.01.016_bib119","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.gendis.2020.01.016_bib120","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.gendis.2020.01.016_bib121","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.4049\/jimmunol.174.8.4670","article-title":"Glucose availability regulates IFN-gamma production and p70S6 kinase activation in CD8+ effector T cells","volume":"174","author":"Cham","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.gendis.2020.01.016_bib122","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nri1710","article-title":"Fuel feeds function: energy metabolism and the T-cell response","volume":"5","author":"Fox","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.gendis.2020.01.016_bib123","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.immuni.2007.07.008","article-title":"Revving the engine: signal transduction fuels T cell activation","volume":"27","author":"Jones","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.gendis.2020.01.016_bib124","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4049\/jimmunol.1003511","article-title":"Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells","volume":"186","author":"Beurel","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.gendis.2020.01.016_bib125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.it.2012.01.010","article-title":"Metabolic pathways in T cell fate and function","volume":"33","author":"Gerriets","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.gendis.2020.01.016_bib126","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib127","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial dynamics controls T cell fate through metabolic programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib128","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2020.01.016_bib129","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses","volume":"162","author":"Ho","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.gendis.2020.01.016_bib130","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2013.05.030","article-title":"The metabolomic window into hepatobiliary disease","volume":"59","author":"Beyo\u011flu","year":"2013","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.gendis.2020.01.016_bib131","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1349-7006.2009.01086.x","article-title":"Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis","volume":"100","author":"Gao","year":"2009","journal-title":"Canc Sci"},{"issue":"5","key":"10.1016\/j.gendis.2020.01.016_bib132","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1053\/j.gastro.2013.01.054","article-title":"Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes","volume":"144","author":"Budhu","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gendis.2020.01.016_bib133","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hep.26350","article-title":"Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification","volume":"58","author":"Beyo\u011flu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.gendis.2020.01.016_bib134","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0163-7258(90)90094-I","article-title":"Metabolism and action of amino acid analog anti-cancer agents","volume":"46","author":"Ahluwalia","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.gendis.2020.01.016_bib135","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1158\/0008-5472.CAN-12-3009","article-title":"Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance","volume":"73","author":"Butler","year":"2013","journal-title":"Canc Res"},{"key":"10.1016\/j.gendis.2020.01.016_bib136","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrc2817","article-title":"Targeting metabolic transformation for cancer therapy","volume":"10","author":"Tennant","year":"2010","journal-title":"Nat Rev Canc"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304220300246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304220300246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:25:13Z","timestamp":1762449913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304220300246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":136,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2352304220300246"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2020.01.016","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The fuel and engine: The roles of reprogrammed metabolism in metastasis of primary liver cancer","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2020.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chongqing Medical University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}